共 50 条
- [31] Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand? FRONTIERS IN ONCOLOGY, 2021, 11
- [32] Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy ONCOLOGIST, 2024, 29 (04): : e498 - e506
- [34] Protocol for mathematical prediction of patient response and survival to immune checkpoint inhibitor immunotherapy STAR PROTOCOLS, 2022, 3 (04):
- [37] Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma FRONTIERS IN IMMUNOLOGY, 2022, 12